New Jersey investigates Amgen's Enbrel activity

01/17/2008 | NYTimes.com · Seattle Times, The

The New Jersey attorney general has asked Amgen to submit documentation on the marketing push and prescription activity for its best-selling psoriasis treatment, Enbrel, following claims of unethical marketing by two former sales representatives. Amgen said it would cooperate with the investigation and said the accusations have no merit.

View Full Article in:

NYTimes.com · Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ